Go Pro

Stock Analyst Initiations

Track the latest stock analyst initiations, newly initiated coverage, and first-time analyst ratings in this regularly updated list of analyst recommendations. This page compiles new initiations, including initial stock ratings, buy/hold/sell recommendations, and price targets, so you can monitor all recent coverage openings across the market.

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Accel Entertainment, Inc. stock logo
ACEL
Accel Entertainment
Initiated by$12.02
-0.7%
$14.00Equal Weight
Amarin Corporation PLC stock logo
AMRN
Amarin
Initiated by $14.11
+0.4%
$13.00Underweight
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
Initiated by $19.19
-1.5%
Market Perform
Builders FirstSource, Inc. stock logo
BLDR
Builders FirstSource
Initiated by$69.99
-0.5%
Market Perform
Builders FirstSource, Inc. stock logo
BLDR
Builders FirstSource
Initiated by $69.99
-0.5%
Market Perform
Bank Of Montreal stock logo
BMO
Bank Of Montreal
Initiated by $174.62
+1.0%
Outperform
Bank of Nova Scotia (The) stock logo
BNS
Bank of Nova Scotia
Initiated by $87.78
+1.6%
Outperform
Canadian Imperial Bank of Commerce stock logo
CM
Canadian Imperial Bank of Commerce
Initiated by $117.05
+1.2%
Market Perform
Emergent Biosolutions Inc. stock logo
EBS
Emergent Biosolutions
Initiated by $4.89
+1.5%
Underweight
Eve Holding, Inc. stock logo
EVEX
EVE
Initiated by $2.69
+5.9%
$6.00Buy
Comfort Systems USA, Inc. stock logo
FIX
Comfort Systems USA
Initiated by$1,662.08
-0.6%
$2,100.00Buy
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
Initiated by$32.08
-0.1%
$56.00Buy
HDFC Bank Limited stock logo
HDB
HDFC Bank
Initiated by $23.63
+1.2%
Buy
ICICI Bank Limited stock logo
IBN
ICICI Bank
Initiated by $30.08
+1.4%
Buy
ImageneBio, Inc. stock logo
IMA
ImageneBio
Initiated by$5.67
+1.1%
$28.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
Initiated by $36.79
+1.4%
$50.00Overweight
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
Initiated by $28.65
+1.3%
Buy
Matthews International Corporation stock logo
MATW
Matthews International
Initiated by$21.46
-0.9%
$24.00Hold
Mobility Global, Inc. stock logo
MBGL
Mobility Global
Initiated by $19.78
-2.1%
$23.00Neutral
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
Initiated by $66.50
+0.2%
$88.00Overweight
Microchip Technology Incorporated stock logo
MCHP
Microchip Technology
Initiated by$75.57
-0.3%
$95.00Outperform
MongoDB, Inc. stock logo
MDB
MongoDB
Initiated by $425.82
+1.3%
$525.00Outperform
MACOM Technology Solutions Holdings, Inc. stock logo
MTSI
MACOM Technology Solutions
Initiated by$267.63
+0.5%
$335.00Market Perform
Micron Technology, Inc. stock logo
MU
Micron Technology
Initiated by $968.05
-0.6%
$1,300.00Outperform
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
Initiated by $74.00
-0.7%
$65.00Neutral
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
Initiated by$6.95
+1.8%
Overweight
Royal Bank Of Canada stock logo
RY
Royal Bank Of Canada
Initiated by $206.13
+0.4%
Market Perform
SpaceX stock logo
SPCX
SpaceX
Initiated by $135.34
+1.0%
$100.00Sell
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
Initiated by $32.20
+2.5%
$40.00Overweight
Skyworks Solutions, Inc. stock logo
SWKS
Skyworks Solutions
Initiated by$66.69
-1.8%
$70.00Market Perform
Toronto Dominion Bank (The) stock logo
TD
Toronto Dominion Bank
Initiated by $117.61
+0.7%
Market Perform
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Initiated by $22.72
+0.7%
Outperform
VMRK
Vivmark Residential Common Shares of Beneficial Interest
Initiated by$66.64
+2.3%
$72.00Equal WeightOverweight
Select Water Solutions, Inc. stock logo
WTTR
Select Water Solutions
Initiated by$19.78
-0.9%
$24.00Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:40 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.